What opportunities are available to investors in the cannabis industry?

Find out in our exclusive report

Learn More »

Cannabis Growth ETF:

Why Active Management Makes Sense

Learn More »

Cannabis Growth ETF:

Providing Access to an Emerging, Growing Industry

Learn More »


Report: Cannabis Deliveries Double In 2021 As More Americans Admit To Marijuana Use, See Tax Upside

Read More »


Foothill Capital and the BUDX team are pleased to provide this brief audio clip summarizing the cannabis industry in 2021 and the future prospects for 2022 and beyond.

Listen to the Audio »


The Board of Trustees of the Trust has approved a Plan of Liquidation for the Cannabis Growth ETF (the “Fund”). The Plan of Liquidation authorizes the termination, liquidation and dissolution of the Fund. The Fund will create and redeem creation units through April 25, 2022 (the “Closing Date”), which will also be the last day of trading of the Fund’s shares on the NYSE Arca, Inc., the Fund’s principal U.S. listing exchange. On or about April 29, 2022 (the “Liquidation Date”), the Fund will cease operations, liquidate its assets, and prepare to distribute proceeds to shareholders of record as of the Liquidation Date.

An Attractive Way To Capitalize In the Growing Cannabis Industry

  • We believe active management is critical in emerging sectors with high volatility and a rapidly evolving backdrop.
  • Active management, in our opinion, can help the investor take advantage of high-quality cannabis related opportunities as they unfold.
  • We can attempt to enhance returns and reduce volatility over time by constructing a diversified, well-researched portfolio.

Industries Expected To Be Disrupted By The Growing Cannabis Industry

Why Invest in the Cannabis Industry

Scales icon

Global Legalization

The global cannabis market is estimated to be valued at USD 20.5 billion in 2020 and is projected to reach USD 90.4 billion by 2026, recording a CAGR1 of 28%. North America accounted for the largest revenue share of 79.6% in 2020.2
Hospital icon

Medical Use

Cannabis and its cannabinoids have been found helpful in treating chronic pain, glaucoma, epileptic seizures and anxiety.
Tea icon

Recreational Use

Cannabis has the potential to be used in an array of consumer products, such as beverages, energy drinks, coffee, alcohol, and other edible products.
Hemp use icon

Hemp Use

The fibers and stalks of the plant are used in clothing, construction, body oil and lotions, plastic, and construction materials.
M&A Activity icon

Robust M&A Activity

As of May 2021, capital raises in cannabis have more than tripled, reaching $6 billion, signaling increased confidence in projected aggressive cannabis market growth.3

1The compound annual growth rate (CAGR) is the rate of return (RoR) that would be required for an investment to grow from its beginning balance to its ending balance, assuming the profits were reinvested at the end of each period of the investment’s life span.

2Source: Grandview Research

3Source: GlobeNewswire

Statements, estimates and forecasts are subject to significant legal, business, economic, and competitive uncertainties. There can be no assurance that such estimates and/or forecasts will be realized, and these are not indicative of future investment performance. Historical data is not indicative of future performance.


Pronouncements from the current Administration suggest the Department of Justice may take action against states to prevent them from implementing laws that authorize medical marijuana use, possession, distribution, and cultivation. This action may have a material effect on investment in companies involved in the cannabis industry.